Featured

Undervalued Biopharmaceutical Giant | Stocks Series .9

Another extraordinary company in the American market that is absolutely undervalued according to its strong balance sheets. Nothing happens by chance, but rather for lack of a basic behavioral and rational approach on the part of individuals who act with extreme greed and also ignorance. The Company I am presenting is 40% (or more) below … Continue reading Undervalued Biopharmaceutical Giant | Stocks Series .9

Featured

Um Tiro Na Lua OU Um Tiro Na Água | Stocks Series .7

Apresentarei uma tese super interessante que envolve ALTÍSSIMO Risco x Retorno. Companhias duradouras que trabalham de acordo com alguns macro ciclos de mercado - seja na economia global, regional ou local. Suas Receitas e Lucros dependem largamente de inúmeras variáveis econômicas, políticas, sociais e naturais. O preço das ações de uma empresa específica do ramo … Continue reading Um Tiro Na Lua OU Um Tiro Na Água | Stocks Series .7

Featured

Weekly Report | Desired Corrections

More indicators correlate expectations of the reality experienced in American and world markets. The Asian markets, Hong Kong and Shanghai, have been undergoing prolonged corrections for almost a year. Alibaba, for example, has already lost 53% of its stock value. Nio - Chinese electric car manufacturer and self-employed - it has lost 41% of its … Continue reading Weekly Report | Desired Corrections

Featured

Very Cheap Japanese Bank | Series .6 Stocks

Getting rid of the "common paths" of the markets has great benefits. This is because the individual moves away from the herd effect; acquires larger volumes of shares of companies that no one cares about at bargain prices and values ​​its equity when every market sees Value in this Company. There are several reports over … Continue reading Very Cheap Japanese Bank | Series .6 Stocks

Featured

Intuições Recessivas

Abaixo segue algumas informações semanais interessantes que nos fazem refletir um pouco mais do momento que estamos vivendo. Vendas no varejo diminuindo drasticamente nos últimos meses contrariando as expectativas positivistas dos investidores. No artigo anterior, encontrado no menu 'News [english/português]' verificou-se muitas distorções acumulativas que indicam uma forte recessão se aproximando: a terceira dos últimos … Continue reading Intuições Recessivas

Featured

URANIUM!

The famous Uranium thesis and future price perspective according to demand. Follow and think about it often on Uranium since 2019, when we confirmed that the numbers will finally be showing all these years. Reflections, beliefs and studies on the concept of the future of the United States, in theory, are simple, or if it … Continue reading URANIUM!

Featured

Urânio!

A famosa tese do Urânio e perspectiva de preço futuro de acordo com a demanda.  Acompanho e penso frequentemente no Urânio desde o fim de 2019, quando comecei confirmar o que os números estavam finalmente demonstrando durante tantos anos. Os pensamentos, raciocínios e estudos sobre o conceito do futuro do Urânio, teoricamente, são simples. O … Continue reading Urânio!

Featured

The Bubble of Everything

ONLY THIS POST WITH ACCESS IS RELEASED TO GIVE A PERSPECTIVE OF WHAT I WRITE. Some still insist on telling and influencing people with the objective of encouraging them to enter into extremely complex and risky situations. It already happened several decades ago, centuries past, and in 2020, it did not happen as designated by … Continue reading The Bubble of Everything

Featured

BREAK NEWS: 2021 American Urological Association Results

In the last post I opened my idea about the biotechnology company that develops the latest generation in the treatment of urethral and kidney cancer. Today, the same company released its latest results on its treatments. BOOM!! Final data from Phase 2b OPTIMA II trial of UGN-102 showed complete and durable response for intravesical instillation … Continue reading BREAK NEWS: 2021 American Urological Association Results

Featured

BREAK NEWS: Resultados da American Urological Association 2021

No último post abri minha ideia sobre a empresa de biotecnologia que desenvolve a última geração no tratamento do câncer uretral e renal. Hoje, a mesma empresa divulgou seus últimos resultados em seus tratamentos. BOOM!! Os dados finais do ensaio de Fase 2b OPTIMA II do UGN-102 mostraram resposta completa e durável para instilação intravesical … Continue reading BREAK NEWS: Resultados da American Urological Association 2021